Search research articles
Contact Us
Filters
Showing results (81-90 of 105) with videos related to
Page
of 11
Sort By:
Transplantation
|
December 20, 2002
Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement
Iain A M Macphee, Salim Fredericks, Tracy Tai, et al.
Transplantation
|
February 25, 2005
Tacrolimus pharmacogenetics: the CYP3A5*1 allele predicts low dose-normalized tacrolimus blood concentrations in whites and South Asians
Iain A M Macphee, Salim Fredericks, Maha Mohamed, et al.
Circulation
|
March 17, 2004
Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris
Juan Cosin-Sales, Michael Christiansen, Paul Kaminski, et al.
Clinical Chemistry
|
August 2, 2013
Standardization of LC-MS for therapeutic drug monitoring of tacrolimus
Thomas M Annesley, Denise A McKeown, David W Holt, et al.
Atherosclerosis
|
December 23, 2008
Asymmetric and symmetric dimethylarginines are of similar predictive value for cardiovascular risk in the general population
Stefan Kiechl, Terry Lee, Peter Santer, et al.
Emergency Medicine Journal : EMJ
|
August 18, 2010
Analysis of recreational drug samples obtained from patients presenting to a busy inner-city emergency department: a pilot study adding to knowledge on local recreational drug use
David M Wood, Panayiota Panayi, Susannah Davies, et al.
Clinical Chemistry
|
October 15, 2011
The need for standardization of tacrolimus assays
Daniel M Levine, Gregory T Maine, David A Armbruster, et al.
Annals of Clinical Biochemistry
|
September 20, 2005
Genotyping cytochrome P450 3A5 using the Light Cycler
Salim Fredericks, Michelle Moreton, Iain A M MacPhee, et al.
Clinical Transplantation
|
April 12, 2007
Multi-drug resistance gene-1 (MDR-1) haplotypes and the CYP3A5*1 genotype have no influence on ciclosporin dose requirements as assessed by C0 or C2 measurements
Salim Fredericks, AnaMaria Jorga, Iain A M MacPhee, et al.
European Journal of Clinical Pharmacology
|
January 22, 2008
Detection of the pharmaceutical agent glaucine as a recreational drug
Paul I Dargan, Jenny Button, Leonard Hawkins, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 105) with videos related to
Sort By:
Page
of 11
Transplantation
|
December 20, 2002
Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement
Iain A M Macphee, Salim Fredericks, Tracy Tai, et al.
Transplantation
|
February 25, 2005
Tacrolimus pharmacogenetics: the CYP3A5*1 allele predicts low dose-normalized tacrolimus blood concentrations in whites and South Asians
Iain A M Macphee, Salim Fredericks, Maha Mohamed, et al.
Circulation
|
March 17, 2004
Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris
Juan Cosin-Sales, Michael Christiansen, Paul Kaminski, et al.
Clinical Chemistry
|
August 2, 2013
Standardization of LC-MS for therapeutic drug monitoring of tacrolimus
Thomas M Annesley, Denise A McKeown, David W Holt, et al.
Atherosclerosis
|
December 23, 2008
Asymmetric and symmetric dimethylarginines are of similar predictive value for cardiovascular risk in the general population
Stefan Kiechl, Terry Lee, Peter Santer, et al.
Emergency Medicine Journal : EMJ
|
August 18, 2010
Analysis of recreational drug samples obtained from patients presenting to a busy inner-city emergency department: a pilot study adding to knowledge on local recreational drug use
David M Wood, Panayiota Panayi, Susannah Davies, et al.
Clinical Chemistry
|
October 15, 2011
The need for standardization of tacrolimus assays
Daniel M Levine, Gregory T Maine, David A Armbruster, et al.
Annals of Clinical Biochemistry
|
September 20, 2005
Genotyping cytochrome P450 3A5 using the Light Cycler
Salim Fredericks, Michelle Moreton, Iain A M MacPhee, et al.
Clinical Transplantation
|
April 12, 2007
Multi-drug resistance gene-1 (MDR-1) haplotypes and the CYP3A5*1 genotype have no influence on ciclosporin dose requirements as assessed by C0 or C2 measurements
Salim Fredericks, AnaMaria Jorga, Iain A M MacPhee, et al.
European Journal of Clinical Pharmacology
|
January 22, 2008
Detection of the pharmaceutical agent glaucine as a recreational drug
Paul I Dargan, Jenny Button, Leonard Hawkins, et al.
Page
of 11